{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:40:48Z","timestamp":1785307248230,"version":"3.55.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Czech Science Foundation","doi-asserted-by":"publisher","award":["17-14631S"],"award-info":[{"award-number":["17-14631S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Czech Science Foundation","doi-asserted-by":"publisher","award":["17-27386S"],"award-info":[{"award-number":["17-27386S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"publisher","award":["R21AI133393"],"award-info":[{"award-number":["R21AI133393"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ijpddr.2018.08.001","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T13:24:32Z","timestamp":1533648272000},"page":"394-402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Validation of Babesia proteasome as a drug target"],"prefix":"10.1016","volume":"8","author":[{"given":"Marie","family":"Jalovecka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Eckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Hajdusek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5695-0409","authenticated-orcid":false,"given":"Anthony J.","family":"O'Donoghue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sojka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2018.08.001_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vetpar.2009.09.049","article-title":"Evaluation of the in vitro growth-inhibitory effect of epoxomicin on Babesia parasites","volume":"167","author":"Aboulaila","year":"2010","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrc1361","article-title":"The proteasome: a suitable antineoplastic target","volume":"4","author":"Adams","year":"2004","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib3","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1158\/1078-0432.CCR-10-1950","article-title":"Nonproteasomal targets of the proteasome inhibitors bortezomib and carfilzomib: a link to clinical adverse events","volume":"17","author":"Arastu-Kapur","year":"2011","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.parint.2014.10.005","article-title":"Phylogeny and evolution of apicoplasts and apicomplexan parasites","volume":"64","author":"Arisue","year":"2015","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.tcb.2010.03.007","article-title":"Assembly, structure, and function of the 26S proteasome","volume":"20","author":"Bedford","year":"2010","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib6","doi-asserted-by":"crossref","first-page":"944","DOI":"10.7326\/0003-4819-107-6-944_1","article-title":"Babesiosis and infection with human immunodeficiency virus (HIV)","volume":"107","author":"Benezra","year":"1987","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib7","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/febs.14029","article-title":"Targeting proteasomes in infectious organisms to combat disease","volume":"284","author":"Bibo-Verdugo","year":"2017","journal-title":"FEBS J."},{"issue":"Suppl. l","key":"10.1016\/j.ijpddr.2018.08.001_bib8","doi-asserted-by":"crossref","first-page":"S247","DOI":"10.1017\/S0031182004005190","article-title":"Babesiosis of cattle","volume":"129","author":"Bock","year":"2004","journal-title":"Parasitology"},{"key":"10.1016\/j.ijpddr.2018.08.001_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/gbe\/evp022","article-title":"Large-scale phylogenomic analyses reveal that two enigmatic protist lineages, telonemia and centroheliozoa, are related to photosynthetic chromalveolates","volume":"1","author":"Burki","year":"2009","journal-title":"Genome Biol Evol"},{"key":"10.1016\/j.ijpddr.2018.08.001_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.vetpar.2006.01.040","article-title":"Expressed sequence tag (EST) analysis of the erythrocytic stages of Babesia bovis","volume":"138","author":"de Vries","year":"2006","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib11","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.1158\/0008-5472.CAN-06-4086","article-title":"Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome","volume":"67","author":"Demo","year":"2007","journal-title":"Canc. Res."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002132","article-title":"Targeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistance","volume":"13","author":"Dogovski","year":"2015","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/clinids\/22.5.809","article-title":"Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin","volume":"22","author":"Falagas","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/B978-0-12-397863-9.00003-1","article-title":"Immunoproteasomes: structure, function, and antigen presentation","volume":"109","author":"Ferrington","year":"2012","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.ijpddr.2018.08.001_bib15","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0140-6736(04)15645-6","article-title":"Babesiosis and HIV","volume":"363","author":"Froberg","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2018.08.001_bib16","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.bbrc.2008.04.133","article-title":"Limitations of SLLVY-AMC in calpain and proteasome measurements","volume":"371","author":"Giguere","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijpara.2012.09.008","article-title":"Bovine babesiosis in the 21st century: advances in biology and functional genomics","volume":"43","author":"Gohil","year":"2013","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.str.2005.11.019","article-title":"Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome","volume":"14","author":"Groll","year":"2006","journal-title":"Structure"},{"key":"10.1016\/j.ijpddr.2018.08.001_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.537","article-title":"Suppression of BRCA1 sensitizes cells to proteasome inhibitors","volume":"5","author":"Gu","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib20","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3201\/eid1607.091905","article-title":"Fatal babesiosis in man, Finland, 2004","volume":"16","author":"Haapasalo","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib21","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s15010-013-0526-8","article-title":"Human babesiosis in Europe: what clinicians need to know","volume":"41","author":"Hildebrandt","year":"2013","journal-title":"Infection"},{"key":"10.1016\/j.ijpddr.2018.08.001_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijmm.2007.01.002","article-title":"First case of human babesiosis in Germany - clinical presentation and molecular characterisation of the pathogen","volume":"297","author":"H\u00e4selbarth","year":"2007","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.ijpddr.2018.08.001_bib23","doi-asserted-by":"crossref","first-page":"10949","DOI":"10.1073\/pnas.1003335107","article-title":"A common red algal origin of the apicomplexan, dinoflagellate, and heterokont plastids","volume":"107","author":"Janouskovec","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ijpddr.2018.08.001_bib24","first-page":"508","article-title":"Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy","volume":"8","author":"Kane","year":"2003","journal-title":"Oncology"},{"key":"10.1016\/j.ijpddr.2018.08.001_bib25","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1158\/1078-0432.CCR-06-0170","article-title":"United States Food and Drug Administration approval summary: bortezomib for the treatment of progressive multiple myeloma after one prior therapy","volume":"12","author":"Kane","year":"2006","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature19339","article-title":"Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness","volume":"537","author":"Khare","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2018.08.001_bib27","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1039\/c3np20126k","article-title":"From epoxomicin to carfilzomib: chemistry, biology, and medical outcomes","volume":"30","author":"Kim","year":"2013","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-biophys-083012-130417","article-title":"Structural biology of the proteasome","volume":"42","author":"Kish-Trier","year":"2013","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.chembiol.2012.01.003","article-title":"Proteasome inhibitors: an expanding army attacking a unique target","volume":"19","author":"Kisselev","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib30","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/525852","article-title":"Persistent and relapsing babesiosis in immunocompromised patients","volume":"46","author":"Krause","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib31","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1182\/blood-2007-01-065888","article-title":"Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma","volume":"110","author":"Kuhn","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ijpddr.2018.08.001_bib32","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1158\/0008-5472.CAN-09-2766","article-title":"Evaluation of the proteasome inhibitor MLN9708 in preclinical models of human cancer","volume":"70","author":"Kupperman","year":"2010","journal-title":"Canc. Res."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib33","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1021\/acs.jmedchem.7b00671","article-title":"Development of a potent inhibitor of the Plasmodium proteasome with reduced mammalian toxicity","volume":"60","author":"LaMonte","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3928\/0090-4481-20020301-10","article-title":"Babesiosis: similar to malaria but different","volume":"31","author":"Lantos","year":"2002","journal-title":"Pediatr. Ann."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/CMR.00022-10","article-title":"Transfusion-transmitted Babesia spp.: bull's-eye on Babesia microti","volume":"24","author":"Leiby","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib36","doi-asserted-by":"crossref","first-page":"16079","DOI":"10.1038\/nmicrobiol.2016.79","article-title":"A global map of genetic diversity in Babesia microti reveals strong population structure and identifies variants associated with clinical relapse","volume":"1","author":"Lemieux","year":"2016","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ijpddr.2018.08.001_bib37","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1111\/febs.13780","article-title":"The cryo-EM structure of the Plasmodium falciparum 20S proteasome and its use in the fight against malaria","volume":"283","author":"Li","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nature16936","article-title":"Structure- and function-based design of Plasmodium-selective proteasome inhibitors","volume":"530","author":"Li","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2018.08.001_bib39","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.chembiol.2012.09.019","article-title":"Validation of the proteasome as a therapeutic target in Plasmodium using an epoxyketone inhibitor with parasite-specific toxicity","volume":"19","author":"Li","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003387","article-title":"Babesia: an emerging infectious threat in transfusion medicine","volume":"9","author":"Lobo","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1051\/vetres:2003047","article-title":"Isolation of Babesia divergens from Carrier cattle blood using in vitro culture","volume":"35","author":"Malandrin","year":"2004","journal-title":"Vet. Res."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib42","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nm.1978","article-title":"A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis","volume":"15","author":"Muchamuel","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijid.2014.12.034","article-title":"Severe human Babesia divergens infection in Norway","volume":"33","author":"M\u00f8rch","year":"2015","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s40588-015-0025-z","article-title":"Human babesiosis: pathogens, prevalence, diagnosis and treatment","volume":"2","author":"Ord","year":"2015","journal-title":"Curr. Clin. Microbiol. Rep."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib45","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12318","article-title":"Acquisition of exogenous haem is essential for tick reproduction","volume":"5","author":"Perner","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.ijpddr.2018.08.001_bib46","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0002-9343(84)90298-5","article-title":"Babesiosis in splenectomized adults. Review of 22 reported cases","volume":"76","author":"Rosner","year":"1984","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib47","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.meegid.2012.07.004","article-title":"Babesia: a world emerging","volume":"12","author":"Schnittger","year":"2012","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165702","article-title":"Mitochondrial genome sequences and structures aid in the resolution of piroplasmida phylogeny","volume":"11","author":"Schreeg","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2018.08.001_bib49","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/cid\/cix477","article-title":"Clinical and molecular evidence of atovaquone and azithromycin resistance in relapsed Babesia microti infection associated with rituximab and chronic lymphocytic leukemia","volume":"65","author":"Simon","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib50","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMcpc079011","article-title":"Case records of the Massachusetts General Hospital. Case 17-2007. A 25-year-old woman with relapsing fevers and recent onset of dyspnea","volume":"356","author":"Stowell","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib51","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-biochem-060410-150257","article-title":"Molecular architecture and assembly of the eukaryotic proteasome","volume":"82","author":"Tomko","year":"2013","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib52","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3109\/00365549209052642","article-title":"First documented case of human babesiosis in Sweden","volume":"24","author":"Uhnoo","year":"1992","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib53","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1056\/NEJMra1202018","article-title":"Human babesiosis","volume":"366","author":"Vannier","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib54","first-page":"357","article-title":"Babesiosis","volume":"29","author":"Vannier","year":"2015","journal-title":"Infect. Dis. Clin."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib55","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.chembiol.2006.09.013","article-title":"A fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in vitro and in vivo","volume":"13","author":"Verdoes","year":"2006","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib56","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.vetpar.2006.01.048","article-title":"Chemotherapy against babesiosis","volume":"138","author":"Vial","year":"2006","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib57","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1146\/annurev.biochem.68.1.1015","article-title":"The 26S proteasome: a molecular machine designed for controlled proteolysis","volume":"68","author":"Voges","year":"1999","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib58","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/649859","article-title":"Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection","volume":"50","author":"Wormser","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib59","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijppaw.2012.11.003","article-title":"Natural history of zoonotic Babesia: role of wildlife reservoirs","volume":"2","author":"Yabsley","year":"2013","journal-title":"Int J Parasitol Parasites Wildl"},{"key":"10.1016\/j.ijpddr.2018.08.001_bib60","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1124\/dmd.111.039164","article-title":"Pharmacokinetics, pharmacodynamics, metabolism, distribution, and excretion of carfilzomib in rats","volume":"39","author":"Yang","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijpddr.2018.08.001_bib61","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1128\/CMR.16.4.622-636.2003","article-title":"Babesia divergens, a bovine blood parasite of veterinary and zoonotic importance","volume":"16","author":"Zintl","year":"2003","journal-title":"Clin. Microbiol. Rev."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320717301574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320717301574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:50:28Z","timestamp":1761922228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320717301574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S2211320717301574"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2018.08.001","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of Babesia proteasome as a drug target","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2018.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}